Fig. 5From: Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong KongCumulative incidence of other liver-related complications after the initiation of DAA therapy, stratified by the presence or absence of previous HCC before DAA therapy. CRR, complete radiologic responseBack to article page